Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Langenbeck'S Archives of Surgery|August 19, 2007
Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapyMorihiko Ishizaki, Tetsuro Sasada, Akane Kunitomi, et al.
Oncotarget|August 25, 2018
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancerMariko Tsukagoshi, Satoshi Wada, Seiko Hirono, et al.
Cancers|March 1, 2019
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver MutationsSusumu Iiizumi, Junya Ohtake, Naoko Murakami, et al.
Cancer Science|June 17, 2017
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapiesShigeru Yutani, Takahisa Shirahama, Daisuke Muroya, et al.
Oncotarget|October 6, 2017
Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapyHidenobu Ishii, Koichi Azuma, Akihiko Kawahara, et al.
Molecular and Clinical Oncology|January 13, 2021
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancerYoshihiro Uchino, Daisuke Muroya, Munehiro Yoshitomi, et al.
Cancer Research|April 17, 2004
Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patientsTetsuro Sasada, Hiroko Takedatsu, Koichi Azuma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Tetsuro Sasada, et al.
Oncotarget|October 23, 2018
Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-GuerinAkihito Hashizume, Susumu Umemoto, Tomoyuki Yokose, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosisMunehiro Yoshitomi, Shigeru Yutani, Satoko Matsueda, et al.
Pageof 14